You are about to leave the Clinical Value website now.
In this interview, Prof Chiu discusses the value of NGS testing to identify lung cancer driver mutations to detect and treat lung cancer early. He alsoā¦
READ MORE
In this interview with Prof Yuen, Chief of Division of Gastroenterology and Hepatology in the University of Hong Kong, explore Hong Kong's current liver health ecosystem,ā¦
READ MORE
In this article, Prof Peter Gibbs and Prof Svetlana Cherepanoff discuss the issues surrounding the clinical integration of NGS in Australia.
READ MORE
NGS and digital applications for oncology management can help improve early cancer detection and prevention, reducing human and economic costs of the cancer. In this article,ā¦
READ MORE
In this article, Dr Amit Rauthan shares insights on the challenges and opportunities for greater NGS adoption in India.
READ MORE
In this video, Prof Henry LY Chan, Deputy Chief Manager at Union Hospital Hong Kong, discusses how PIVKA-II can complement AFP and Ultrasound in assisting cliniciansā¦
READ MORE
In this article, Dr Lam Tai-Chung shares how his institution has had first-hand experience of landmark cases and outstanding treatment responses from using NGS in seeminglyā¦
READ MORE
In this article, Dr David Tan discusses the potential of NGS in Singapore, where the adoption of this technology is only just beginning to take root.
READ MORE
In this article, Prof Jee Hyun Kim explains her clinical experiences of NGS, and how she sees it evolving within South Koreaās innovative healthcare ecosystem.
READ MORE
While precision oncology has shown great promise, there are still barriers to its implementation, such as data fragmentation, staff shortages and time, funding, and lack ofā¦
READ MORE
A/Prof Simone Strasser recently published an independent commentary in the Australian Medical Research and Journal "Research Review", covering at length topics such as non-alcoholic liver diseaseā¦
READ MORE
In this video, Prof Ming-Lung Yu, Chair Professor of Hepatology at Kaohsiung University Medical Hospital, discusses how PIVKA-II can complement AFP and Ultrasound in assisting cliniciansā¦
READ MORE
In this video, Dr Bao Toan Nguyen from MEDIC-LAB Ho Chi Minh discusses how PIVKA-II can complement AFP in assisting clinicians in the early detection andā¦
READ MORE
In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinicalā¦
READ MORE
Liver disease is a serious public health issue in Taiwan. The Liver Disease Prevention and Treatment Research Foundation, Taiwan, is one of Asiaās most active andā¦
READ MORE
Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection. Yet unmet needs continue to affect theā¦
READ MORE
More than 27,000 patients in Thailand are found to have liver cancer each year, making it the most-frequently diagnosed cancer in the country. With emerging riskā¦
READ MORE
Punjab is one of Pakistanās largest provinces and has a particularly high HCV prevalence rate of roughly 9%, compared to 5.4% for Pakistanās total population. Hearā¦
READ MORE
In line with the WHO Essential Diagnostics List (EDL) and Lancet Commission efforts, the Asia Pacific Medical Technology Association and its members recently came together toā¦
READ MORE
In 2019, Pakistan announced a nationwide programme to scale up HCV prevention, testing and treatment. Hear from gastroenterologist Dr Huma Qureshi, a key figure in Pakistanāsā¦
READ MORE
An estimated 71 million people around the world are chronically infected with hepatitis C virus (HCV), with a large proportion currently being undiagnosed or diagnosed late.ā¦
READ MORE
In 2018, the worldās largest HCV screening campaign was initiated in Egypt. Within 7 months following its initiation, 49.5 million people were screened; and 2.2 millionā¦
READ MORE
The province of Sindh has one of the worldās highest rates of HCV infection and bears the second highest disease burden of both HBV and HCVā¦
READ MORE
Pakistan has one of the worldās highest rates of HCV infection. Learn from Dr Zaigham Abbas, Head of Gastroenterology at Ziauddin University Hospital and President ofā¦
READ MORE
Pakistan has one of the worldās highest rates of HCV infection. It's no surprise that their healthcare systems face mounting pressure from HCV-related conditions. Learn fromā¦
READ MORE
Hepatitis B is an important infectious disease problem in the APAC region. Learn from Prof Henry Chan, director of the Center for Liver Health at Chineseā¦
READ MOREPakistan has one of the worldās highest rates of HCV infection. It's no surprise that their healthcare systems face mounting pressure from HCV-related conditions. Learn from Prof Aamir Khan, Headā¦
Read MoreAn estimated 71 million people around the world are chronically infected with hepatitis C virus (HCV), with a large proportion currently being undiagnosed or diagnosed late. There is an urgentā¦
Read MoreIn 2018, the worldās largest HCV screening campaign was initiated in Egypt. Within 7 months following its initiation, 49.5 million people were screened; and 2.2 million HCV-seropositive individuals were referredā¦
Read More
